-
Something wrong with this record ?
Late diagnosis of mucopolysaccharidosis type IVB and successful aortic valve replacement in a 60-year-old female patient
G. Dostalova, Z. Hlubocka, J. Lindner, H. Hulkova, H. Poupetova, H. Vlaskova, J. Sikora, A. Linhart, J. Zeman, M. Magner,
Language English Country United States
Document type Case Reports, Journal Article
Grant support
NV15-27682A
MZ0
CEP Register
- MeSH
- Aortic Valve diagnostic imaging pathology physiopathology surgery transplantation MeSH
- Aortic Valve Stenosis diagnostic imaging etiology physiopathology surgery MeSH
- beta-Galactosidase genetics MeSH
- Bioprosthesis MeSH
- Biopsy MeSH
- Time Factors MeSH
- Heart Valve Prosthesis Implantation * instrumentation MeSH
- Echocardiography MeSH
- Calcinosis diagnostic imaging etiology physiopathology surgery MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Imaging MeSH
- Mucopolysaccharidosis IV complications diagnosis genetics MeSH
- Mutation MeSH
- DNA Mutational Analysis MeSH
- Delayed Diagnosis MeSH
- Heart Valve Prosthesis MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
Mucopolysaccharidosis type IVB (MPS IVB) is a very rare lysosomal storage disorder characterized by skeletal dysplasia, hearing disorder, and cardiac valvular disease. Herein, we report an extremely rare manifestation of MPS IVB in a 60-year-old female patient who underwent a successful aortic valve replacement. The patient presented with mild coarse facial features, short stature, mild dyspnea, sternal protrusion, mild lumbar hyperlordosis, and waddling gait owing to bilateral femoral head necroses and bilateral arthrosis of the knees. The patient also suffered from dyspnea, NYHA II-III. Echocardiography revealed severe stenosis of a calcified aortic valve (AVA 0.67 cm2, AVAi 0.45 cm2/m2, PG max/mean 130/80 mmHg), left ventricular hypertrophy with predominant septal thickening (18 mm) and mild left ventricle outflow tract obstruction at rest, mild mitral valve regurgitation, and dilated ascending aorta (36 mm, 26.5 mm/m2). Dyspnea resolved after septal myectomy and replacement of the aortic valve with bioprosthesis. Excretion levels and spectrum of glycosaminoglycans (GAGs) in urine were normal in the patient. We confirmed the diagnosis of MPS IVB by identifying decreased beta-galactosidase activity in isolated leukocytes (6 nmol/h/mg; controls 95-272) and by molecular genetic analyses (c.438_440delTCT and c.817_818TG>CT mutations in the GLB1 gene). Primary lysosomal storage of glycosaminoglycans was detected in fibroblasts of the aortic valve. Additional pathologies included valvular fibrosis, calcification, neovascularization, and mild chronic inflammation. In conclusion, the diagnosis of MPS IVB should be considered in older patients with cardiac valvular disease and progressive skeletal abnormality even if urinary excretion levels of GAGs are normal.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000702
- 003
- CZ-PrNML
- 005
- 20190114115634.0
- 007
- ta
- 008
- 190107s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.carpath.2018.04.001 $2 doi
- 035 __
- $a (PubMed)29800929
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Dostalova, Gabriela $u 2(nd) Department of Internal Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 245 10
- $a Late diagnosis of mucopolysaccharidosis type IVB and successful aortic valve replacement in a 60-year-old female patient / $c G. Dostalova, Z. Hlubocka, J. Lindner, H. Hulkova, H. Poupetova, H. Vlaskova, J. Sikora, A. Linhart, J. Zeman, M. Magner,
- 520 9_
- $a Mucopolysaccharidosis type IVB (MPS IVB) is a very rare lysosomal storage disorder characterized by skeletal dysplasia, hearing disorder, and cardiac valvular disease. Herein, we report an extremely rare manifestation of MPS IVB in a 60-year-old female patient who underwent a successful aortic valve replacement. The patient presented with mild coarse facial features, short stature, mild dyspnea, sternal protrusion, mild lumbar hyperlordosis, and waddling gait owing to bilateral femoral head necroses and bilateral arthrosis of the knees. The patient also suffered from dyspnea, NYHA II-III. Echocardiography revealed severe stenosis of a calcified aortic valve (AVA 0.67 cm2, AVAi 0.45 cm2/m2, PG max/mean 130/80 mmHg), left ventricular hypertrophy with predominant septal thickening (18 mm) and mild left ventricle outflow tract obstruction at rest, mild mitral valve regurgitation, and dilated ascending aorta (36 mm, 26.5 mm/m2). Dyspnea resolved after septal myectomy and replacement of the aortic valve with bioprosthesis. Excretion levels and spectrum of glycosaminoglycans (GAGs) in urine were normal in the patient. We confirmed the diagnosis of MPS IVB by identifying decreased beta-galactosidase activity in isolated leukocytes (6 nmol/h/mg; controls 95-272) and by molecular genetic analyses (c.438_440delTCT and c.817_818TG>CT mutations in the GLB1 gene). Primary lysosomal storage of glycosaminoglycans was detected in fibroblasts of the aortic valve. Additional pathologies included valvular fibrosis, calcification, neovascularization, and mild chronic inflammation. In conclusion, the diagnosis of MPS IVB should be considered in older patients with cardiac valvular disease and progressive skeletal abnormality even if urinary excretion levels of GAGs are normal.
- 650 _2
- $a aortální chlopeň $x diagnostické zobrazování $x patologie $x patofyziologie $x chirurgie $x transplantace $7 D001021
- 650 _2
- $a aortální stenóza $x diagnostické zobrazování $x etiologie $x patofyziologie $x chirurgie $7 D001024
- 650 _2
- $a bioprotézy $7 D001705
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a kalcinóza $x diagnostické zobrazování $x etiologie $x patofyziologie $x chirurgie $7 D002114
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a opožděná diagnóza $7 D057210
- 650 _2
- $a echokardiografie $7 D004452
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční chlopně umělé $7 D006350
- 650 12
- $a chirurgická náhrada chlopně $x přístrojové vybavení $7 D019918
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mukopolysacharidóza IV $x komplikace $x diagnóza $x genetika $7 D009085
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a beta-galaktosidasa $x genetika $7 D001616
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hlubocka, Zuzana $u 2(nd) Department of Internal Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Lindner, Jaroslav $u 2(nd) Department of Surgery-Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Hulkova, Helena $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Poupetova, Helena $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Vlaskova, Hana $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Sikora, Jakub $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Linhart, Ales $u 2(nd) Department of Internal Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Zeman, Jiri $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Magner, Martin $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Electronic address: martin.magner@vfn.cz.
- 773 0_
- $w MED00008594 $t Cardiovascular pathology the official journal of the Society for Cardiovascular Pathology $x 1879-1336 $g Roč. 35, č. - (2018), s. 52-56
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29800929 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190114115844 $b ABA008
- 999 __
- $a ok $b bmc $g 1363904 $s 1038825
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 35 $c - $d 52-56 $e 20180412 $i 1879-1336 $m Cardiovascular pathology $n Cardiovasc Pathol $x MED00008594
- GRA __
- $a NV15-27682A $p MZ0
- LZP __
- $a Pubmed-20190107
